Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report

L A Schweickert; M Strober; A Moskowitz

doi:10.1002/(sici)1098-108x(199704)21:3<299::aid-eat11>3.0.co;2-w

Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report

Int J Eat Disord. 1997 Apr;21(3):299-301. doi: 10.1002/(sici)1098-108x(199704)21:3<299::aid-eat11>3.0.co;2-w.

Authors

L A Schweickert¹, M Strober, A Moskowitz

Affiliation

¹ Neuropsychiatric Institute and Hospital, School of Medicine, University of California at Los Angeles 90024-1759, USA.

PMID: 9097204
DOI: 10.1002/(sici)1098-108x(199704)21:3<299::aid-eat11>3.0.co;2-w

Abstract

This case describes the beneficial effect on the binge eating component of bulimia nervosa of methylphenidate, which was prescribed to treat comorbid attention-deficit/hyperactivity disorder. Possible mechanisms of action are discussed.

Publication types

Case Reports

MeSH terms

Adult
Attention Deficit Disorder with Hyperactivity / drug therapy*
Attention Deficit Disorder with Hyperactivity / epidemiology
Bulimia / drug therapy*
Bulimia / epidemiology
Central Nervous System Stimulants / therapeutic use*
Comorbidity
Female
Humans
Methylphenidate / therapeutic use*

Substances

Central Nervous System Stimulants
Methylphenidate